Oculogica

Focus: Oculogica develops non-invasive eye-tracking devices for neurological applications, with a focus on brain concussion and traumatic brain injury detection. The company is a small-scale biotech operation based in New Richmond, Wisconsin.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Oculogica

AI assessmentNot Hiring

No open roles listed right now. Follow Oculogica to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

EyeBOX

Impairment

N/A

Clinical Trials (1)

NCT04799093Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication

N/A

Help build intelligence for Oculogica

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused technology platform with 7 active clinical programs centered on high-need neurology indications including traumatic brain injury and concussion detection
Early-stage company offers potential for significant individual impact and equity upside as core EyeBox platform matures
Novel non-invasive diagnostic approach addresses unmet need in rapid TBI/concussion assessment with broad clinical applications

Watch Out For

Minimal public financial data and lack of disclosed funding stage create uncertainty about runway, burn rate, and sustainability
Only 1 active job opening suggests minimal near-term hiring and possible resource constraints or early operational phase

Generated by Claude from Oculogica's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

EyeBOX for ICP

Intracranial Pressure Increase

N/A

Clinical Trials (1)

NCT03418753Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

N/A

EyeBOX Model EBX-4

Concussion, Brain

N/A

Clinical Trials (1)

NCT05047003Oculogica Portable EyeBOX Study

N/A